Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer

被引：16
|
作者：
Belani, CP [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Lung & Thorac Canc Program, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期
关键词：
D O I：
10.1053/sonc.2002.34255
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 9
页数：6
相关论文
共 50 条
  • [1] Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
    W. Schuette
    I. Bork
    B. Wollschläger
    S. Schädlich
    [J]. Clinical Drug Investigation, 2001, 21 : 161 - 168
  • [2] Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer
    Schuette, W
    Bork, I
    Wollschläger, B
    Schädlich, S
    [J]. CLINICAL DRUG INVESTIGATION, 2001, 21 (03) : 161 - 168
  • [3] A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
    Kasahara, Kazuo
    Kimura, Hideharu
    Shibata, Kazuhiko
    Araya, Tomoyuki
    Sone, Takashi
    Oribe, Yoshitaka
    Furusho, Shiho
    Kita, Toshiyuki
    Shirasaki, Hiroki
    Oribe, Yoshitaka
    Yoshimi, Yuzo
    Ueda, Akihito
    Tachibana, Hideki
    Shintani, Hiromoto
    Mizuguchi, Masayuki
    Nishi, Kohichi
    Fujimura, Masaki
    Nakao, Shinji
    [J]. ANTICANCER RESEARCH, 2006, 26 (5B) : 3723 - 3728
  • [4] Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer
    Nagel, Sylke
    Califano, Raffaele
    Thatcher, Nicholas
    Blackhall, Fiona
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (18) : 3265 - 3275
  • [5] Retrospective analysis of administration of a combination of docetaxel and carboplatin for advanced non-small cell lung cancer
    Bando, H
    Miyata, J
    Sano, T
    Sumitomo, M
    [J]. ANTICANCER RESEARCH, 2001, 21 (3C) : 2107 - 2113
  • [6] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non-small cell lung cancer: Interim analysis
    Belani, C
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (03) : 10 - 14
  • [8] Combination chemotherapy including ifosfamide, carboplatin, and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Sorensen, JB
    Larsen, H
    Hansen, HH
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1108 - 1108
  • [9] Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer
    Le Chevalier, T
    Bérille, J
    Zalcberg, JR
    Millward, MJ
    Monnier, A
    Douillard, JY
    McKeage, MJ
    James, R
    Soulas, F
    Loret, C
    Bougon, N
    Bizzari, JP
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (03) : 13 - 18
  • [10] Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer
    Barata, F
    Camacho, E
    Sousa, A
    Costa, MS
    Resende, R
    Meleiro, A
    Nogueira, F
    Pereira, A
    Canário, D
    [J]. LUNG CANCER, 2005, 49 : S235 - S235
12345